ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,735.50
0.22%
S&P ASX All Technology
3,073.40
0.22%
Brent Oil
86.515
0.08%
US Dollar vs AUD
1.4987
-0.06%
Bitcoin
61,047.40
-1.58%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Organicell Regenerative Medicine Inc (QB) (OCEL)

  7. Organicell Regenerative Medicine Inc (QB) (OCEL) News

OCEL

Organicell Regenerative ... (QB) (OCEL)

Organicell Regenerative Medicine Inc (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:OCEL
DateTimeSourceHeadlineSymbolCompany
28/11/202309:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
15/11/202308:29Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
19/10/202321:56Edgar (US Regulatory)Form PRER14C - Information statementsUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
29/09/202304:54Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
15/09/202306:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
26/08/202305:13Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
15/08/202306:34Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
10/08/202306:05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
02/08/202306:15Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
26/07/202323:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
12/07/202307:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
12/07/202306:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
01/07/202306:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
01/07/202306:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
29/06/202323:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
29/06/202323:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
29/06/202306:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
29/06/202306:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:OCELOrganicell Regenerative Medicine Inc (QB)
21/06/202322:46Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
17/06/202306:07Edgar (US Regulatory)Quarterly Report (10-q)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
15/06/202306:02Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
10/06/202306:36Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
10/06/202306:06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
16/05/202306:10Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
02/05/202306:06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
22/04/202306:06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
18/03/202307:17Edgar (US Regulatory)Quarterly Report (10-q)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
09/03/202308:06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
15/02/202308:59Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
15/02/202308:39Edgar (US Regulatory)Annual Report (10-k)USOTC:OCELOrganicell Regenerative Medicine Inc (QB)
 Showing the most relevant articles for your search:USOTC:OCEL

Your Recent History

FX
AUDJPY
AUD vs Yen
NYSE
MCD
McDonalds
ASX
WOW
Woolworths
ASX
ORG
Origin Energy
NYSE
DIS
Walt Disney
ASX
NCM
Newcrest Mining
NASDAQ
GOOGL
Alphabet
NASDAQ
NVDA
NVIDIA
PM
XAUUSD
Gold vs US Dollar
CCOM
SILVER
SILVER
COIN
BTCUSD
Bitcoin
NYSE
JPM
JP Morgan Chase
ASX
ANZ
Australia And New Zealan...
ASX
QBE
QBE Insurance
ASX
WPL
Woodside Petroleum
ASX
XFL
S&P ASX 50
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved